Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Cloughesy

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Seminars in Oncology|November 15, 2011
The impact of recent data on the optimization of standards of care in newly diagnosed glioblastomaTimothy Cloughesy
Future Oncology (London, England)|August 17, 2012
Bevacizumab as first-line therapy for glioblastomaDavid Piccioni, Albert Lai, Phioanh Nghiemphu, et al.
Neuro-Oncology|November 9, 2012
Standards of care for treatment of recurrent glioblastoma--are we there yet?Michael Weller, Timothy Cloughesy, James R Perry, et al.
International Journal of Oncology|November 12, 2014
A novel bicompartmental mathematical model of glioblastoma multiformeLeith Hathout, Benjamin M Ellingson, Timothy Cloughesy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2007
18F-FDOPA kinetics in brain tumorsChristiaan Schiepers, Wei Chen, Timothy Cloughesy, et al.
Journal of Neuro-Oncology|March 16, 2004
A prospective blinded study of the predictive value of an extreme drug resistance assay in patients receiving CPT-11 for recurrent gliomaRicardo J Parker, John P Fruehauf, Rita Mehta, et al.
Psycho-Oncology|July 12, 2002
Predicting major depression in brain tumor patientsDavid K Wellisch, Thomas A Kaleita, Donald Freeman, et al.
Journal of Neuro-Oncology|August 25, 2012
A dose escalation trial for the combination of erlotinib and sirolimus for recurrent malignant gliomasPhioanh Leia Nghiemphu, Albert Lai, Richard M Green, et al.
Pharmacogenomics and Personalized Medicine|December 11, 2012
Update and developments in the treatment of glioblastoma multiforme - focus on bevacizumabNaveed Wagle, Leia Nghiemphu, Albert Lai, et al.
Neuro-Oncology|September 25, 2008
The L84F polymorphic variant of human O6-methylguanine-DNA methyltransferase alters stability in U87MG glioma cells but not temozolomide sensitivityMaya Remington, Jana Chtchetinin, Karen Ancheta, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Seminars in Oncology|November 15, 2011
The impact of recent data on the optimization of standards of care in newly diagnosed glioblastomaTimothy Cloughesy
Future Oncology (London, England)|August 17, 2012
Bevacizumab as first-line therapy for glioblastomaDavid Piccioni, Albert Lai, Phioanh Nghiemphu, et al.
Neuro-Oncology|November 9, 2012
Standards of care for treatment of recurrent glioblastoma--are we there yet?Michael Weller, Timothy Cloughesy, James R Perry, et al.
International Journal of Oncology|November 12, 2014
A novel bicompartmental mathematical model of glioblastoma multiformeLeith Hathout, Benjamin M Ellingson, Timothy Cloughesy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2007
18F-FDOPA kinetics in brain tumorsChristiaan Schiepers, Wei Chen, Timothy Cloughesy, et al.
Journal of Neuro-Oncology|March 16, 2004
A prospective blinded study of the predictive value of an extreme drug resistance assay in patients receiving CPT-11 for recurrent gliomaRicardo J Parker, John P Fruehauf, Rita Mehta, et al.
Psycho-Oncology|July 12, 2002
Predicting major depression in brain tumor patientsDavid K Wellisch, Thomas A Kaleita, Donald Freeman, et al.
Journal of Neuro-Oncology|August 25, 2012
A dose escalation trial for the combination of erlotinib and sirolimus for recurrent malignant gliomasPhioanh Leia Nghiemphu, Albert Lai, Richard M Green, et al.
Pharmacogenomics and Personalized Medicine|December 11, 2012
Update and developments in the treatment of glioblastoma multiforme - focus on bevacizumabNaveed Wagle, Leia Nghiemphu, Albert Lai, et al.
Neuro-Oncology|September 25, 2008
The L84F polymorphic variant of human O6-methylguanine-DNA methyltransferase alters stability in U87MG glioma cells but not temozolomide sensitivityMaya Remington, Jana Chtchetinin, Karen Ancheta, et al.
Pageof 10